[1] |
HONG Ye, NIU Xue⁃hua, SHEN Yu⁃zhou, ZHOU Lei, HUANG Li⁃ping.
Effectiveness of FibroTouch combined with four hepatic fibrosis biomarkers for evaluation of the liver fibrosis degree among patients with chronic schistosomiasis⁃induced liver disorders
[J]. Chinese Journal of Schistosomiasis Control, 2021, 33(6): 629-.
|
[2] |
ZHOU Li-Yun, ZHANG Li-Fang, WU Yi-Ming, HAN Shuang-Yin.
Association between serum vitamin D level and immune imbalance in advanced schistosomiasis patients with liver fibrosis
[J]. Chin J Schisto Control, 2021, 33(1): 22-.
|
[3] |
LV Ye-Chao, TANG Xiao-Niu, HU Wei, JIANG Yu-Xin, ZHAN Xiao-Dong, GUO Wei, SUN Qi-Shan, WANG Guo-Dong, ZHOU Shu-Lin.
Preliminary study on molecular detection of polysaccharide from Amusium pleuronectes and its intervention to hepatic fibrosis in rats infected with Schistosoma japonicum
[J]. Chin J Schisto Control, 2018, 30(5): 500-503,517.
|
[4] |
LI Hang, LU Zhi-Yan.
Imaging findings and progress of schistosomal hepatopathy
[J]. Chin J Schisto Control, 2017, 29(5): 656-659.
|
[5] |
WANG Huan, LU Ya-Jing, GAO Yan-Ru, WANG Shu-Hong, ZHOU Rui, DONG Hui-Fen.
Changes of liver fibrosis-related miRNAs induced by soluble egg antigen of Schistosoma japonicum
[J]. Chin J Schisto Control, 2017, 29(2): 192-196.
|
[6] |
XIE Yuan-Yuan, XU Yuan-Hong, CHU De-Yong, SHEN Ji-Long.
Progress in researches on macrophages in liver fibrosis of schistosomiasis
[J]. Chin J Schisto Control, 2015, 27(6): 669-.
|
[7] |
SONG Lan-Gui, WU Zhong-Dao.
Pathology and pathogenesis of liver fibrosis induced by Schistosoma japonicum
[J]. Chin J Schisto Control, 2015, 27(2): 213-.
|
[8] |
YANG Dong-Ming, TU Ye-Ping, HONG Wen-Xia.
Clinical significance of changes of lipid in elderly patients with hepatic schis?
tosomiasis
[J]. Chin J Schisto Control, 2015, 27(1): 66-.
|
[9] |
ZHANG Lan, LIU Xiong, ZHANG Hua-Ming, WANG Qing-Shan.
Laparoscopic surgical treatment for schistosomiasis liver fibrosis portal hypertension combined with calculous cholecystitis
[J]. Chin J Schisto Control, 2014, 26(2): 230-.
|
[10] |
GE Hua-Jie, BAI Ding-Hua, XIA Xiao-Ling, XU Sha-Ting, LUO Fu-Jun, REN Guang-Hui.
Curative effect of Ruangan pills in treatment of schistosomiasis liver fibrosis
[J]. Chin J Schisto Control, 2014, 26(2): 197-.
|
[11] |
YANG Dong-Ming.
Influencing factors in elderly patients with schistosomiasis liver disease combined with gallbladder diseases
[J]. Chin J Schisto Control, 2014, 26(2): 194-.
|
[12] |
WU Yi-Ming, XU Xiao-Fei, WU Wen-Lin, WU Wan-Xin, GAO Shu-Xin, ZHU Wen-Jun.
Correlation between levels of liver fibrosis and liver fibrosis biochemical parameters of advanced schistosomiasis patients
[J]. Chin J Schisto Control, 2014, 26(1): 65-.
|
[13] |
ZHANG Hong-Xia, LI Jun, WANG Yi-Hui, CHENG Chun.
Abdominal indwelling central venous catheter in treatment of liver fibrosis and intractable ascites
[J]. Chin J Schisto Control, 2013, 25(4): 427-.
|
[14] |
WU Zhong-Lian, HE Li.
Advances in traditional Chinese medicine treatment of schistosomiasis liver fibrosis
[J]. Chin J Schisto Control, 2013, 25(4): 422-.
|
[15] |
NIU Xue-Hua, HUA Hai-Yong, GUO Wen-Jian, ZHANG Yu, LIU Min, HONG Ye, WU Peng-Fei, LU Ping, ZHANG Hai-Fang.
Clinical efficiency of tanshinone IIA-sulfonate in treatment of liver fibrosis of advanced schistosomiasis
[J]. Chin J Schisto Control, 2013, 25(2): 137-.
|